Skip to content

iPSC-Based Assays

Smarter Decisions Stem From Ncardia

When you need iPSC-based assays to model human biology in a lab setting for your drug discovery, toxicology or disease research, partner with Ncardia, the proven iPSC experts.

Ncardia-22

Robust and Reliable iPSC-Based Assays

With iPSC technology expertise and profound understanding of its applications, we can develop everything from pilot and validation studies to full screening campaigns. We offer a multitude of cell models, technologies and readouts that can be combined and applied to any therapeutic modality:

  • Monoculture, co-culture and triculture models
  • 2D or 3D formats
  • Low to high throughput
  • Multiplexing

Discover our broad range of technology platforms and iPSC assay endpoints.

Custom Assay Development

0104 NCARDIA BENEFIT ICONS-2_Cells

iPSC-Derived Cell Types

  • Ventricular Cardiomyocytes
  • Atrial Cardiomyocytes
  • Neurons
  • Astrocytes
  • Microglia
  • Endothelial Cells
  • Smooth Muscle Cells
  • Patient-Derived Cells
  • 2D and 3D Formats
0104 NCARDIA OUR PROCES ICONS-2_process - step 4

Readouts

  • Cell Viability
  • Cell Morphology
  • Gene and Protein Expression
  • Biomarker Detection
  • Electrophysiological activity
  • Organelle characterization
  • Live cell imaging (phagocytosis)
  • Calcium signaling
  • Cell painting
  • Metabolism
0104 NCARDIA BENEFIT ICONS-2_safety - Consistency and sensitivity

Analytical Platforms

  • High Content Imaging
  • Incucyte
  • Automation for HTS
  • Multi-Electrode Array (MEA)
  • FDSS - Calcium Imaging
  • Mesoscale Discovery Platform (MSD)
  • FACS
  • Plate Readers
  • qPCR
  • Impedance
your-discoveries

High-Throughput iPSC-Based Assays

Integrating iPSC-based assays into large screening campaigns doesn’t have to be a challenge anymore. Our team has the capabilities and expertise to:

  • Miniaturize and reduce costs
  • Automate relevant cell-based assays
  • Keep a strong focus on delivering high-quality and reproducible data

Partner With the Proven iPSC Experts

Are you ready to confidently advance your therapeutic candidates?

Start a Conversation